Elucidation of the Molecular Mechanisms Underlying Sorafenib-Induced Hepatotoxicity

Figure 1

Plasma liver markers. Whole blood samples were used to separate plasma and measure the liver enzymes and liver markers. Data are presented as . Comparison between the control group and the sorafenib group is presented by , where , while . n.s. means there were no significant changes (). SORA: sorafenib; ALT: alanine transaminase; ALP: alkaline phosphatase; AST: aspartate aminotransferase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very low-density lipoprotein.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)